2019

22/11/2019 2019 AGM CEO's Speech

22/11/2019 2019 AGM Chairman's Address

19/11/2019 Mayne Pharma continues expansion of dermatology pipeline

13/11/2019 Mayne Pharma completes E4/DRSP transaction

23/10/2019 E4/DRSP contraceptive presented at EU gynecology conference

21/10/2019 Notice of Annual General Meeting/Proxy Form

21/10/2019 Retirement of Director

02/10/2019 Mayne Pharma signs 20-year license agreement for novel oral contraceptive in the US

27/08/2019 Mayne Pharma announces PBS listing of Kapanol^® for chronic breathlessness

23/08/2019 FY19 Results Media Release

22/05/2019 FDA Approves Sorilux for Adolescent Plaque Psoriasis

14/05/2019 Mayne Pharma Market Update

22/02/2019 HY19 Results Media Release

19/02/2019 Mayne Pharma Announces New Chronic Breathlessness Indication for Kapanol^® by TGA

13/02/2019 Mayne Pharma Launches Lexette™ (Halobetasol Propionate) Foam 0.05% in the US

30/01/2019 Mayne Pharma Tolsura (SUBA^®-itraconazole) capsule now launched in the US